ASH 2013: Dr. John Byrd Discusses ONO-4059 and... - CLL Support

CLL Support

23,086 members39,645 posts

ASH 2013: Dr. John Byrd Discusses ONO-4059 and IPI-145 for the Treatment of CLL

bkoffman profile image
bkoffmanCLL CURE Hero
2 Replies

Hi friends,

New drugs in the pipeline. Some will make it to clinical use and some won't. We need as many options as possible. No single drug is a home run for everyone.

My blog bkoffman.blogspot.com has the second part of my interview from ASH with Dr. Byrd on this topic.

Stay strong

Brian

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
2 Replies
vepiskop profile image
vepiskop

Great news Brian! Many thanks for these incredibly informative interviews and for bringing us the latests news from ASCO. Is there an estimate of how fast ONO will be approved? What would its price be? You wisely mentioned that its approval will create competition for Ibrutinib and this will drop the prices of ibrutinib.

Over here in the UK, even the clinical trials with ibrutinib get stuck in bureaucracy. NHS is already in deep deficit and saving is they way proposed to overcome it. The prospect of getting Ibrutinib approved in the UK is very low unless its price is lowered and becomes reasonable. It is the only hope to get it over here.

Again many thanks for all you have been offering non-stop to our CLL community all these years.

vepiskop

bkoffman profile image
bkoffmanCLL CURE Hero

Thanks for the kind words. Pharma does this cost analysis that can prove that many expensive but highly effective meds really save money in the long run. An ounce of prevention, …. Not sure who buys that logic. Payers are so short sighted.

Not what you're looking for?

You may also like...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

Friends In another interview from ASH 2013 that I just posted on my blog...

ASH 2014. Dr. Sharman discusses the biology of our CLL cells

Friends, This week on the CLL Society website http://cllsociety.org, we share the first part of an...

Dr Peter Hillmen of Leeds, UK discusses the place for Idelalisib in CLL treatment (Patient Power Video)

In this short video taken at iwCLL Collogne Germany, Andrew Schorr interviews Dr Hillmen: "As a...

ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib

ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies...

ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL

Today we posted on ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of...